RecruitingPhase 2NCT06642220

Ablative Radioembolization of Renal Cell Carcinoma Trial

Studying Chromophobe renal cell carcinoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Derek W. Cool
Intervention
Y-90 Selective Internal Radiation Therapy (SIRT)(device)
Enrollment
16 enrolled
Eligibility
18 years · All sexes
Timeline
20252032

Study locations (1)

Collaborators

Boston Scientific Corporation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06642220 on ClinicalTrials.gov

Other trials for Chromophobe renal cell carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Chromophobe renal cell carcinoma

← Back to all trials